Obstacles to successful treatment of hepatitis C in uninsured patients from a minority population

@inproceedings{DeBoseScarlett2018ObstaclesTS,
  title={Obstacles to successful treatment of hepatitis C in uninsured patients from a minority population},
  author={Alexandra DeBose-Scarlett and Raymond R. Balise and Deukwoo Kwon and Susan T Vadaparampil and Steven Xi Chen and Eugene R Schiff and Gladys Patricia Ayala and Emmanuel Thomas},
  booktitle={Journal of Translational Medicine},
  year={2018}
}
BackgroundHepatitis C virus (HCV) treatment regimens (DAAs) are well tolerated, efficacious but costly. Their high cost and restricted availability, raises concerns about the outcome of treatment in uninsured patients. This study investigated sustained virologic response (SVR) outcomes in a predominately uninsured patient population and completion of four steps along the HCV treatment cascade.MethodsA retrospective chart review was conducted to characterize the patient population and analyze… CONTINUE READING
1
Twitter Mention

Citations

Publications citing this paper.

References

Publications referenced by this paper.
SHOWING 1-10 OF 32 REFERENCES

Viral hepatitis: past and future of HBV and HDV.

VIEW 4 EXCERPTS

Disability evaluation under social security—diges‐ tive system. 2018. https ://www.ssa.gov/disab ility /profe ssion als/blueb ook/5.00‐Diges tive‐Adult .htm

  • SS Administration
  • 2018
VIEW 1 EXCERPT

C FAQs for Health Professionals

  • CDC. Hepatiti
  • 2017. https ://www.cdc. gov/hepat itis/hcv/hcvfa q.htm. Accessed 18 Nov
  • 2017
VIEW 1 EXCERPT